Mr Brian Leedman is a biotechnology entrepreneur having co-founded seven healthcare companies on the ASX. Digital respiratory diagnostics company, ResApp Health Limited, in which he served as the executive director of corporate affairs was acquired by Pfizer in 2022. Mr Leedman also served as Chairman of Neurotech International Limited, Nutritional Growth Solutions Limited, Neuroscientific Biopharmaceuticals Limited and Ausbiotech (WA). He was a Director of Alcidion Corporation Limited, Oncosil Medical Limited, Respiri Limited and a founder of Imugene Limited. Previously, he spent a decade as the vice president of investor relations at ASX, Nasdaq and Frankfurt listed, pSivida Corporation (renamed Eyepoint Therapeutics) and held senior marketing positions at Westpac Banking Corporation and Ernst & Young. He holds a B.Econs and an MBA from the University of Western Australia.
Meet the rest of our team!
With the roots of our company lying in the neurological research field, our team is built from strong academic knowledge gained at prestigious institutions such as Princeton University and Erasmus MC.
.png)
